The RSPCA has reported a dramatic increase in the number of cats being abandoned.
The number of abandonments reported to the RSPCA was 10,610 in 2010, a 28% increase on the number reported in 2009 (8,310), and a 40% increase on the number in 2008 (7,609).
The charity received 205 reports of cats being shot in 2010, more or less the same as the year before. However, the charity says anecdotal reports suggest the number of cats being attacked (including being set upon by dogs or thrown from buildings) is increasing.
RSPCA chief veterinary officer, Alastair Macmillan, said: "The news of massive rises in abandonments and other attacks is alarming and shows a frightening trend in cat abuse and neglect. We don't know why we are seeing such increases and hope that people are not starting to see cats as worthless things which can be targeted with weapons or just dumped when people don't want to care for them anymore".
Zoetis says the new product is designed to stimulate both cell-mediated and antibody-based immunity, providing a broad immune response that mimics a natural infection.
The company says CircoMax Myco has demonstrated robust performance in field conditions, delivering improvements in average daily gain (ADG) and close-out weights versus negative controls, helping producers get more kilograms of pork to market.
CircoMax Myco comes in a ready to use single-dose combination with a duration of immunity (DOI) of 23 weeks against both PCV2 and M. hyopneumoniae.
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: “The swine industry needs to adapt to evolving challenges and our research has consistently demonstrated that with its unique technology CircoMax Myco offers robust protection against PCV2 and M. hyopneumoniae.
"It also shows that this new product offers the best chance at protection against continuously evolving PCV2 genotypes – providing a broader umbrella for pig health and productivity.
"Analysis of new European PCV2 strains isolated in multiple countries confirm that CircoMax Myco offers broader coverage than competitor vaccines based on PCV2a only.”
Pfizer Animal Health's Equine Herpes Virus (EHV) vaccine (Duvaxyn EHV 1,4) has been rebranded Equip EHV 1,4).
Pfizer says that EHV is carried by most horses in the UK1 and can cause respiratory disease, abortion and more rarely neurological disease. However, it is the more common sub-clinical infections that pose the most apparent issue for the competition client, with the associated loss of performance and the potential effect on the health of the whole yard.
Once infected with EHV, a horse can harbour the virus throughout its life and potentially shed the disease to other animals without showing any outward signs. According to the company, vaccinating helps to minimise the severity of the disease itself and importantly, can also help to reduce the amount of infective virus that is shed to other in-contact horses.
Equip EHV 1,4 is given as a primary course of two vaccinations, 4-6 weeks apart followed by a single dose every six months. It can also be used as an aid in the control of EHV-1 abortion - pregnant mares should be vaccinated with a single dose during each of the 5th, 7th and 9th months of pregnancy.
For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients contact your Pfizer Account Manager or Pfizer Animal Health, Walton Oaks, Tadworth, Surrey KT20 7NS.
Reference
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142.
The Animal Health Trust has begun a pilot study to investigate a possible link between seasonal canine illness (SCI) and harvest mites, continuing an initial study on the possible cause of SCI funded by the Kennel Club.
SCI is a mystery illness which in recent years has made a number of dogs walked in woodlands suddenly become ill.
Cases of SCI are usually seen from August to November, with dogs showing clinical signs of vomiting, diarrhoea and/or lethargy within 24 to 72 hours of walking in woodland. Dog owners are advised to seek immediate veterinary advice should they see these signs in their dog following a woodland walk.
So far this year, there have been 49 cases in total reported to the AHT, from across all of its current investigation sites. A number of cases reported to the charity have shown evidence of harvest mite infestation.
Charlotte Robin, SCI Research Co-ordinator at the AHT, said: "To enable us to eliminate harvest mites as a potential cause of SCI, we are advising dog owners to treat their dogs with a fipronil spray directly before walking in woodlands."
There are currently no licenced products that will specifically prevent against harvest mites, however fipronil spray is believed to be effective in preventing other mites. The researchers believe that it is important that dog owners use the spray and not the spot-on treatment, which may not provide the same level of localised protection on vulnerable areas.
Charlotte added: "Dog owners need to be aware that using fipronil spray may not protect their dog from SCI, but it could protect them from harvest mites and other external parasites. What we are trying to do with this study is eliminate the harvest mite and other external parasites from our enquiries.
In addition to advising all dog owners walking their dogs in woodlands during autumn to use fipronil spray as an external parasite treatment, the AHT is working with the Sandringham Estate in Norfolk to offer to offer dog owners who wish to participate in the study access to the spray free of charge, if deemed appropriate by their veterinary surgeon.
As this is a prescription only medicine, the charity is issuing vouchers to dog owners which they can redeem for fipronil spray through their local vet practice, on the proviso their dog is deemed a suitable candidate by their vet.
Dog owners who meet the criteria and wish to participate in the study will be required to complete a SCI online questionnaire following their visit to the Estate, and an additional follow-up questionnaire regarding the pilot study, regardless of whether their dog was taken ill or not.
You can register to take part in the pilot study at www.aht.org.uk/scipilotstudy
Image courtesy: Luc Viatour / www.Lucnix.be
At the outset of the hearing, Mr Kashiv, from Vets & Pets, Broxbourne, denied all aspects of the charges against him. During the course of the inquiry, some heads of charge were not pursued and some he admitted, leaving the remaining heads of charge to be determined.
The charges concerned the treatment of a Scottish Terrier, called Tanzy, whose owner, Mrs Greenhill, brought her in to see Mr Kashiv on 5 March 2015. Mrs Greenhill was concerned about blood in Tanzy’s urine and swellings in her mammary glands. After carrying out a cytopathology test, Mr Kashiv advised Mrs Greenhill that Tanzy would require surgery to remove the mammary glands. There were no further tests conducted, and no alternatives to surgery suggested.
On 13 March another veterinary surgeon at Vets & Pets therefore undertook a right-side mammary strip on Tanzy, discharging her the following day. On 17 March Mrs Greenhill brought Tanzy back in for a post-operative check and was seen by a locum veterinary surgeon, who found her to be in good condition.
On 20 March Mrs Greenhill then became concerned about Tanzy’s deteriorating condition and returned her to see Mr Kashiv. He admitted Tanzy for observation over the weekend but did not conduct any further tests at that stage, apart from radiography on 22 March. The hospitalisation records were of poor quality and substantially incomplete.
On 23 March Mr Kashiv then informed Mrs Greenhill that Tanzy could be discharged, although he recommended an MRI scan to assist in the diagnosis; this was declined on cost grounds. He did not however explain clearly to Mrs Greenhill that Tanzy’s prognosis was bleak, and did not give adequate home care instructions.
Tanzy continued to deteriorate, and on 24 March Mrs Greenhill took Tanzy to the RSPCA Harmsworth Hospital where a veterinary surgeon conducted tests which showed that Tanzy was in renal failure. The veterinary surgeon then called Mrs Greenhill and recommended that Tanzy was put to sleep, which was then performed in Mrs Greenhill’s presence.
The Committee found that Mr Kashiv had failed to conduct the necessary investigations when Tanzy was admitted from 20 to 23 March 2015, being satisfied that, by the time Tanzy had been hospitalised for a period of three days, it was mandatory for a blood test to have been performed, given her marked deterioration.
The Committee also found while Mr Kashiv did express his opinion that Tanzy’s prognosis was poor, he did not give the full explanation required in the circumstances of this case to enable Mrs Greenhill to understand fully the prognosis. The Committee also considered that Tanzy was not in a fit state to be discharged on 23 March 2015, and that he had failed to keep sufficiently clear and/or detailed and/or accurate records.
After full consideration, the Committee found that Mr Kashiv’s actions amounted to serious professional misconduct, and was satisfied that his actions fell far short of the conduct to be expected of a reasonably competent veterinary surgeon in respect of heads of charge 1, 2 and 3 but not 4.
Although it was concerned "about the culture of care in the practice, in particular not having in place proper protocols and procedures and without necessary support from properly trained staff", in deciding on appropriate sanction, the Committee was satisfied that there were "a number of serious misjudgements by Mr Kashiv in this case".
The Committee decided to postpone judgement for a period of two years, whilst recommending that Mr Kashiv agree to undertake a structured programme to benefit his clinical practice including a Personal Development Plan, mentoring, practice visits, additional CPD and regular reports to the Disciplinary Committee.
Non-compliance with these undertakings may result in the hearing being resumed at a date earlier than the two-year period.
Stuart Drummond, Chairing the Disciplinary Committee and speaking on its behalf, said: "The Committee considers that Mr Kashiv is a dedicated veterinary surgeon, as evidenced by the large number of testimonials, and that he provides a valuable service to the community, particularly with rescue animals.
"Nevertheless, the Committee considers that there were a number of fundamental failings in Mr Kashiv’s clinical competence which are required to be addressed during the period of postponement. For the reasons set out above the Committee considers that Mr Kashiv’s clinical practice will benefit from a structured programme over the period of postponement, whilst protecting the welfare of animals, maintaining public confidence in the profession and declaring and upholding proper standards of conduct."
For the full charges, findings and decisions, see: http://www.rcvs.org.uk/concerns/disciplinary-hearings/
The RCVS has announced the names of the candidates standing in the Council elections this year and is, once again, inviting veterinary surgeons to put questions to them directly in this year’s 'Quiz the candidates'.
There are eight candidates (well, seven really, if you exclude the 'Donald Trump' candidate) contesting six places in the RCVS Council, including four existing Council members eligible for re-election and four new candidates. They are:
Ballot papers and candidates’ details are due to be posted to all veterinary surgeons eligible to vote during the week commencing 14 March, and all votes must be cast, either online or by post, by 5pm on Friday, 29 April 2016.
To submit a question to the candidates, email it (NB only one per person) to vetvote16@rcvs.org.uk, post it on the College’s Facebook page (www.facebook.com/thercvs) or on twitter using the hashtag #vetvote16, by midday on Monday, 29 February.
Each candidate will then be invited to choose two questions to answer from all those received, and produce a video recording of their answers. All recordings will be published on the RCVS website on Thursday 17 March.
RCVS Chief Executive Nick Stace said: "Last year, all election candidates produced videos for the first time and, with over 3,500 views in total, it seemed a popular way for voters to find out more about the individuals who were standing.
"Providing a way for all vets and vet nurses to put their own questions to the candidates is now an integral part of the elections, and one which we hope will continue to encourage people to get involved and have their say."
The £11m project, which is backed by Mars Petcare, will include a cutting-edge imaging suite, state-of-the-art treatment facilities and a new linear accelerator.
Plans also include separate cat and dog waiting areas and client walking and comfort areas, seven operating theatres, 15 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and plans for a future hydrotherapy suite.
Daniel Hogan, operations manager at Southfields (pictured right), said: "This is a really exciting time for Southfields and our relocation will provide the region with one of the largest and best-equipped veterinary centres in the UK.
"The team and expertise have grown significantly in the past 18 months. We are very excited to continue to expand the unique and innovative offerings in patient care at our centre.
"Increasing in size will also enable us to provide a dedicated staff wellbeing area and an education centre and lecture hall, which will offer some very exciting qualifications and courses for the wider profession.
"Since our rebranding in 2017, we pride ourselves on leading the industry as a truly multidisciplinary centre with specialists from across the globe, including one of the most illustrious oncology teams in the country. Once this new site is launched, we will be able to offer an even more comprehensive service to our clients and patients."
For more information about Southfields, visit www.southfields.co.uk.
The work done by vetsurgeon.org and vetnurse.co.uk attempted to identify the sorts of unpleasant behaviour that veterinary surgeons and and nurses found themselves on the receiving end of, and the impact that it had on them. It was not, however, able to quantify the prevalence of these types of behaviour other than to the extent that there were 677 reports.
The new survey of over 650 vet nurses and student vet nurses found that not only did 96% agree or strongly agree that bullying and incivility is a serious problem in the profession, but 70% of respondents had personally experienced a mental health concern as a result.
Other findings from the survey were:
The full findings of the survey will be revealed at the MMI Student Veterinary Nurse Wellbeing Discussion Forum, taking place on Wednesday 3rd November.
Attendees will have the opportunity to discuss the challenges highlighted in the survey and how they can be addressed. The results will also be published at a session led by Jill McDonald, VN Futures Project Coordinator at BVNA Congress, taking place Saturday 2nd – Monday 4th October.
Lisa Quigley, Mind Matters Initiative Manager, said: “A number of our survey findings are extremely concerning, particularly the high levels of bullying, incivility and discrimination reported by participants. We conducted the survey with the intention of finding out more about what systemic issues across workplace practices were impacting on the profession’s mental health.
"We want to thank everyone who took part and shared their experiences with us. There were some upsetting accounts shared with us about experiences of bullying and discrimination – no one should go through this at any point in their life, let alone at their place of work.
"Decisive action needs to be taken to tackle this and we will be using the findings of the survey to help form our 2022-2027 strategy and decide what resources and training we create for the profession. Supporting the wellbeing of veterinary nurses and student veterinary nurses is one of our key priorities, and will be part of all future MMI activities.”
“I would encourage as many veterinary nurses and student veterinary nurses as possible to attend the upcoming Student Veterinary Nurse Wellbeing Discussion Forum and our session at BVNA to have your voice heard about what steps need to be taken to improve the mental wellbeing of the profession.
"We recognise that these results may bring some difficult emotions to the fore for many people, and we would encourage anyone who has experienced bullying or discrimination to seek help from an organisation such as Vetlife or the National Bullying Helpline.
"I would urge anyone who witnesses bullying or discrimination in the workplace to speak out, wherever it is safe to do so. This takes immense courage, but it is only by calling out this behaviour that it can begin to be addressed. We will be launching Active Bystander training in early 2022, to equip people with the confidence to call out unacceptable behaviour, and the skills to proactively support colleagues who have been targeted.”
Matthew Rendle, Chair of the RCVS Veterinary Nurses Council, added: “As a veterinary nurse some of these results were a difficult read and I would like to thank those student vet nurses and newly qualified vet nurses who came forward with great honesty and bravery with their views and experiences, as it couldn’t have been easy.
“We take these matters very seriously and opening up the conversation is an important first step. I hope that, following these results, we can take look at things such as strengthening reporting mechanisms for bullying and discrimination and encouraging better workplace practices to mitigate against these incidents.
“While it’s easy to focus on the negatives, I do think that these survey results have given us positive steps to build on, not least that people know how to access mental health support so they’re not suffering in silence and the role that our amazing clinical coaches are playing in supporting people with their mental health, and how we can better give them the tools for this support.”
The resource includes content from Companion, BSAVA Congress, and the BSAVA Manual of Wildlife Casualties.
Topics range from hand-rearing to anaesthesia to relevant legal questions and cover both hedgehogs and general wildlife casualties.
Liz Mullineaux, RCVS Recognised Specialist in Wildlife Medicine (Mammalian), Senior Vice President of the British Veterinary Zoological Society, and editor of the BSAVA Manual of Wildlife Casualties, said: "Hedgehogs are the most common mammalian wildlife casualty seen by veterinary surgeons.
"Those caring for these animals have very variable knowledge and look to vets for appropriate help, advice, and clinical care.
"It’s therefore really important that vets and vet nurses in practice have some good information about hedgehogs to hand.
"As well as knowing about clinical conditions, a broader understanding of wildlife rehabilitation is essential.
The collection, which costs £20.00 for BSAVA members or £45.00 for non-members, can be accessed via the BSAVA Library: https://www.bsavalibrary.com/content/hedgehogs.
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
Elisa, pictured right next to Bill Oddie, is the founding member of a craft conservation charity called Blankets for Baby Rhinos. In less than three years the group has amassed a Facebook community of around 3,500 members, primarily knitters, crocheters and crafters, to make blankets and other items to supply to wildlife centres taking in orphaned and sick rhinos in Africa, as well as other wildlife threatened by poaching.
Originally from South Africa, Johannesburg-born Elisa had planned to work as a vet treating wildlife but found herself working in small animal practice in Cape Town before moving to the UK.
Still, colleagues and friends often told her of the injuries they saw inflicted on rhinos targeted for the illegal trade in their horns, so she and a friend decided to help.
After building a following and supplying thousands of blankets for a growing number of wildlife orphanages in Africa, she wanted to harness the enthusiasm of members to help meet the other practical needs of the centres, as well as helping rangers and dogs working in anti-poaching units.
Now a registered charity, members supply all kinds of equipment including animal feed, medicine and veterinary supplies to a wide list of centres, as well as food for anti-poaching dogs while continuing to run appeals which crafters can assist with. Currently they are asking knitters to knit hats, scarves and blankets in black or dark colours for rangers, so they can keep warm at night without being spotted by poachers.
James Sawyer, UK Director of IFAW, said: "Elisa’s pioneering approach to harnessing practical public support to help rhinos and other rescued African wildlife is really impressive and she is a great example of animal welfare in action. We hope her efforts will inspire the next generation of animal welfare and conservation campaigners. She is a very deserving winner of IFAW’s Vet of the Year Award."
Companion Care Vets has opened its first new standalone joint venture surgery in Ayr, Scotland.
At 3,071 sq ft the £300,000 surgery is the largest of the groups' 86 strong network and is the first standalone surgery to be opened under the joint venture partnership model that has been in place since 2001.
The surgery is located in a retail park environment, to give easy access for clients and their pets. It is a full service practice, which Companion Care says is fitted with all the latest equipment, including digital x-ray machines and a full operating suite.
Managing Director, Jane Balmain, said: "The opening of our first new standalone surgery in Ayr is a real milestone for us as a business because it opens up our offering to the vets and veterinary nurses who are interested in a joint venture partnership, but whose preference is to have a more traditional looking standalone surgery."
Whilst the Ayr surgery is standalone in its own right, due to the unique relationship Companion Care Vets has with Pets at Home, the surgery works in close partnership with the local Pets at Home store. This will help to drive client registrations and business development and further enable Pets at Home to develop the full pet care experience for its customers.
Jane added: "We believe that this new venture offers any potential partner the best of both worlds: a superb in-store surgery with footfall of thousands of customers a month, or a standalone new surgery linked to local store network to develop the business. I don't believe any other company can offer this unique proposition."
Veterinary surgeon, and joint venture partner of the Ayr surgery, Kirstin Fyfe says, "I am extremely proud to be opening the first standalone surgery alongside the Companion Care team and the facilities available to my team and I and local pet owners are fantastic. The latest equipment, coupled with a spacious and modern waiting area and the convenience of our location is what makes this a winning formula."
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
As part of the partnership between the two companies, anyone who takes part in one of Improve's CPD courses in 2018 will be entitled to 6 months' half-price pet insurance from Agria.
Online Bitesize CPD modules cover topics including: cardiology, ophthalmology, small animal medicine, feline medicine and exotic animals. Modules are 20, 40 or 60 minutes in length and provide veterinary professionals with interactive experiences which count toward annual CPD requirements in short convenient bursts, earning digital badges and certificates to demonstrate total CPD achieved.
Nick White, Head of Veterinary Channel at Agria, said: "We’re delighted that our partnership with Improve International will give veterinary professionals free, instant access to high-quality and engaging CPD. Not only are the modules available varied and highly relevant, the 'bitesize' nature of the training makes it extremely convenient for busy practice staff to access.
"This is a great incentive for any practices not yet working with Agria to get onboard. As well as benefitting from free CPD, practices will also be working with a specialist lifetime insurer offering 5 weeks free insurance policies and much more for clients and their pets."
For more information, contact your Agria Business Development Manager or visit: www.agriapet.co.uk/bitesize and complete the Contact Us section, using 'FREE CPD' in the subject line of the enquiry box.
The web based app, which has been launched in association with the BSAVA, provides a library of medical summaries drawn from global guidelines and peer-reviewed journals.
Vet2Vet co-founder Dr Zoe Coker said “There is rarely time during the working day to read all the necessary journals, articles and up-to-date texts. VETbytes collates all the evidence on a specific medical condition and consolidates it into a short synopsis called a Keep it Simple Summary (KISS)."
BSAVA President Professor Ian Ramsey said: “BSAVA is excited and proud to be involved in the VETbytes project, which should provide significant benefits and support for our members. Every busy small animal clinician should try out VETbytes as it is a real paradigm shift in mobile resources for vets.”
The VETbytes app currently covers more than 100 topics developed in consultation with more than 25 veterinary experts. Further benefits include drug (and CRI) calculators, a quick reference section and links to hundreds of source abstracts. The content encourages reflective learning and can be used towards CPD hours.
VETBytes is available on subscription with reduced rates for BSAVA members and free access for veterinary students.
To start a free trial or subscribe to the VETbytes app, visit www.vetbytes.co.uk.
The company surveyed 1979 pet owners last December and found the main reason they didn’t take their cat to the vet more often was because the animal appeared to be healthy and therefore didn’t need medical attention.
The second biggest barrier to more regular vet visits was cost. Although almost half of the cat owners surveyed had pet insurance, almost a quarter said cost prevented them from taking their cat to the vet more often.
Despite there being 760 cat-friendly clinics across the UK and Ireland, 13% percent of owners said the stress put them off making more frequent trips to the vet.
If they were unable to take their cat to the vet, 40% said they would arrange for a vet home visit, 29% said they would search for information online and 26% would turn to friends and family for advice.
The survey also found that 11% of owners believed that their cat was overweight. However, according to a 2018 study, 39% of cats are overweight in the UK, which would suggest that over a quarter of cat owners surveyed were unaware that their cat was above a healthy weight.
References
Researchers and practitioners working in any field of academia, industry and/or clinical practice are invited to apply for an award of up to £2,000 to fund a research project relevant to the aims of the VMG, which represents veterinary professionals working in leadership and management roles.
The VMG says it has launched the scheme to help veterinary leaders embrace the challenges and opportunities faced by the sector and to help them to continue to meet patient needs effectively while remaining profitable.
VMG Junior Vice President Mr Richard Casey said: "Business landscapes are changing and the veterinary world is no exception. The VMG is ideally placed not only to support our members but also to help the wider profession. We hope that our grant scheme will support research that enhances our understanding of contemporary veterinary business, leadership and management and helps us to develop a solid evidence base for best practice. We are looking forward to receiving some exciting proposals."
Further information, including the Stage 1 application form and guidance notes, are available here: https://www.vetmg.com/vmg-research-awards/
The deadline for applications is 19 July 2019.
Part of the VN Futures project, the lunchtime webinars will be delivered between February and June 2020 via the Webinar Vet, and the College is encouraging all veterinary surgeons, nurses, practice managers and owners to attend, as it says the webinars will benefit the whole practice team.
All three webinars take place at 12.30pm and last one hour. They are as follows:
Tuesday 4 February 2020 – ‘Maximising the potential of the veterinary nurse’ presented by Louise Northway RVN, BVNA Council member and recipient of the RCVS Inspiration Award. The webinar will give an overview of the role of veterinary nurses under Schedule 3 of the Veterinary Surgeons Act, how VNs can develop their role in practice and take on extra responsibilities and how VNs can approach these conversations in practice through the creation of learning and development plans. This webinar will illustrate how fully utilising the nursing team not only hugely boosts the morale of the work force, but also enhances patient care and increases the efficiency of the business.
Tuesday 10 March 2020 – ‘Veterinary nurses’ time is valuable: How and why to charge for it’ presented by Stephanie Writer-Davies MRCVS, Career Progression Working Group member, and Jane Davidson RVN, VN Council member and regular blogger on veterinary nursing issues. This webinar will provide examples and case studies of how veterinary nurses contribute to practice finances, how practice pricing structures can be developed so that the financial value of veterinary nurses’ time and effort can be better highlighted, and how veterinary nurses can demonstrate their value to clients.
Tuesday 23 June 2020 – ‘Lead or Head RVN: What’s in a name?’ presented by Gillian Page RVN, President of the Veterinary Management Group. This webinar will look at the role of the traditional Head RVN and how development of ‘Lead RVNs’ in different areas of practice can help to allow for growth of other talented team members and provide increased and shared responsibility and progression. This webinar will explore how this enhances practice efficiency alongside development of team members, thus increasing job satisfaction and, ultimately, retention.
Racheal Marshall, Chair of RCVS Veterinary Nurses Council and the VN Futures Board, said: "We hope that veterinary nurses will engage with these webinars in order to gain some inspiration about how they can truly show their value to their team, their clients and the wider public.
"The VN Futures research clearly demonstrated that there was a desire from the veterinary nursing profession to find ways in which VNs could gain greater recognition for the work they do and progress in their careers. These webinars, and our talented presenters, will provide many practical examples and case studies on how this can be done, help build confidence and highlight opportunities for further learning and development."
To sign up to the free webinars, visit: https://www.thewebinarvet.com/sponsors/VN%20Futures.
The company has also carried out research amongst 60 practices which found that despite the fact that over 80% of dogs over the age of three reportedly suffer from dental disease1, only 48% opened discussions about dental care at the earliest opportunity: vaccination time. 16% only discussed dental care if the dog developed a dental problem and 52% also admitted that they did not follow up discussions on dental compliance.²
Eleanor Workman Wright, Product Manager at Animalcare, said: "The key to successful dental care is to start early, both in educating owners and getting puppies and kittens used to brushing or other forms of dental care. If discussions are delayed until the animal is a year old, it is possible that some disease may already be present while the animal may be less receptive to brushing or other efforts to care for their teeth.
"We see the dental sector as important and one that is likely to grow, particularly in the light of the pandemic-induced increase in the number of dogs and cats. We hope that our new Owner Guide will support veterinary teams in initiating early discussions with owners about the importance of dental care, while the addition of an affordable and effective oral gel in Orozyme, to our range will give them a key tool to offer to owners to use as part of their homecare routine."
For more information, contact your Animalcare Territory Manager or visit: www.animalcare.co.uk .
Vets Now Referrals has launched a new specialist veterinary referral service to serve Aberdeen and the North.
Richard Coe MA VetMB CertSAS DipECVS MRCVS (pictured right) and Professor Stuart Carmichael BVMS MVM DSAO MRCVS will attend Ardene House Veterinary Hospital in Aberdeen on a monthly rotational basis to offer specialist care to pets from the area. Richard is a European Specialist in Small Animal Surgery and Professor Carmichael is an internationally recognised expert in veterinary orthopaedics.
By bringing these two specialist surgeons to Aberdeen, it will mean that vets can refer their clients to have their initial consultations and diagnoses locally by either Richard or Stuart, reducing the need for a lengthy journey to Vets Now Referrals in Glasgow where they are usually based. Vets Now says that where possible, treatment plans will be carried out in Aberdeen, however complex treatments may require the facilities and high tech equipment at its Glasgow Hospital.
Any vet wishing to make an enquiry about referring to Richard or Stuart should call 01224 478 041. Further information about the service can also be found on www.vetsnowreferrals.com/aberdeen.
Tricia Colville, Hospital Manager of Vets Now Referrals, Glasgow, said: "We are delighted to now be able to offer our specialist service for vets in the North of Scotland to utilise for their clients. The Vets Now Referrals Hospital in Glasgow has been so successful since it opened over a year ago, benefiting hundreds of pets and their owners. Bringing the service to Aberdeen and the surrounding region will provide vets with local access to Richard Coe and Professor Stuart Carmichael who are both renowned in their fields and for their clients this provides a convenient option which will greatly reduce time-consuming, distressing and costly journeys for them."
Co-edited by Paddy Dixon and Vicki Nicholls, the collection comprises ten studies on physiology, disease, diagnosis and treatment techniques in equine dentistry. The editors say it gives veterinary surgeons free access to some of the most important current research in the UK.
The studies include:
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "Care of the horse’s teeth is fundamental to good health. To this end a strong working knowledge of equine dentistry should be seen as an essential cornerstone for every equine practitioner. This diverse collection has the convenience of being easily accessible, online and in one place to help keep vets fully abreast of the excellent research currently being conducted in the UK."
Vicki Nicholls, incoming president of BEVA, continued: "Advances in equine dentistry continue to gather pace and it has been a pleasure and privilege to work with Paddy Dixon collating the most current dental research that will be relevant to all equine practitioners with any level of expertise."
The equine dentistry collection is available free online at: http://bit.ly/2bBDuMW.
In mid-September, the Association wrote to the RCVS expressing concern about the August extension to the temporary guidance.
In the latest update from the RCVS, the temporary measure has now been extended to 31 October but the flowchart and guidance have been updated to add some additional steps before a POM-V product can be prescribed remotely.
The BVA says that while it supported the original decision in March as a pragmatic solution and direct response to government restrictions surrounding Covid-19, it is now questioning the ongoing need for such a relaxation in the rules.
In the letter to the RCVS, the BVA also asked for a timeframe for the publication of the results of the RCVS survey of practices’ experiences of remote consulting and prescribing. The Association's own under care working group, chaired by Nigel Gibbens, has been developing a position to respond to the RCVS review.
BVA President James Russell (pictured right) said: "We understand that allowing remote prescription of POM-Vs was a necessary measure at the height of the lockdown, as practices struggled to assess patients in person.
"However, the veterinary professions have done a fantastic job in adapting to the restrictions and are now able to work safely and see patients.
"Whilst we recognise the RCVS has provided additional guidance for the remote prescribing of POM-V, we cannot currently see any reason why a new client would be unable to access in-person veterinary care in the first instance and we are asking RCVS Council to reconsider this measure when it meets in Oct.
"It makes sense to continue allowing vets to remotely prescribe for existing patients, for example if an owner is shielding, but we feel it is no longer appropriate to be remotely prescribing to animals that have never been physically examined by the vet.
“The question of whether we should be able to remotely prescribe POM-V products without first seeing an animal is an important and live debate, and we welcome the resumption of the College’s review. But the longer that temporary measures are in place, the greater the expectation from animal owners that they will always be in place, and the harder it will be to have the discussion about the best way forward.
“As a profession, we are rightly concerned about antimicrobial resistance and we pride ourselves on the responsible use of medicines. Continually extending the temporary measures without a full analysis would risk undermining our position.”
The PIC decision marked the conclusion of its investigation into a concern that was raised formally last November involving allegations of bullying at Professor Argyle’s workplace, the University of Edinburgh.
Professor Argyle, who had previously decided to step aside from his JVP and Council duties until the concern was investigated and concluded, said: “Despite this outcome from the PIC discussions, I have now made the challenging decision to stand down from my position at the RCVS. This is to ensure there is no further distraction to the College’s important work and activities and that whoever becomes the next JVP has the full support of Council and RCVS members.
"It is also to reduce the toll this situation has taken on my family, colleagues and students, and on me personally. I am proud and privileged to have served on RCVS Council for nearly ten years and wish it well as it navigates the next chapter in its history."
RCVS President Mandisa Greene said: “I appreciate that this has been an exceptionally difficult situation and very upsetting for all involved.
"I understand why David has taken the difficult decision to stand down from RCVS Council and would like to thank him for his many years of service to the RCVS since joining Council in 2012.
"I would also like to reassure colleagues once again that, throughout, the College has remained firmly committed to following due, proper and fair process in all its regulatory activities."
Following Professor Argyle’s decision to step down, the process for electing a new JVP for the current presidential year will commence.
As Professor Argyle was a Veterinary Schools Council appointee on RCVS Council, it will be for that body to elect a replacement Council member.
Further details will be announced in due course.
Founded in 2005 by Jane Howorth MBE, the British Hen Welfare Trust rehomes commercial laying hens that would usually be sent to slaughter, typically at 18 months.
The charity has rehomed hens in schools, community areas, prisons and back gardens around the country, where they have plenty of life left both as egg layers and companions.
The millionth hen, named Henrietta by His Majesty, was rehomed at Highgrove Gardens in Gloucestershire, along with 30 others earlier this month.
Jane said: “We’re thrilled that one million hens have been adopted and extremely pleased that Henrietta and her 30 feathered friends are heading to Highgrove Gardens.
"Helping a lorry load of 4,000 was my original target and we’ve exceeded my expectations by some margin!
"To think that so many hens have had a happy retirement gives me a great deal of pleasure as I’m sure it has for all the kind-hearted British supporters who’ve taken these deserving little creatures into their homes and hearts.
"From the day I started this charity, it’s been a privilege to meet and work with people who want to help hens and to work alongside the egg industry to champion hen welfare and free range eggs.”
www.bhwt.org.uk/one-millionth-hen.
Bayer Animal Health has announced that its parasiticide - Advocate Spot-On Solution - is now licensed to be used weekly, and for a prolonged period of time, in severe cases of demodicosis in dogs.
According to the company, recent work carried out to obtain the new weekly indication shows a number of benefits of this increased application frequency for severely affected animals. Dogs treated on a weekly basis showed a greater reduction in mite numbers, fewer clinical signs, and improved hair regrowth and weight gain over the trial period, when compared to dogs treated monthly.
Advocate remains licensed for monthly use on mild to moderate presentations.
A spokesperson for the company said: "The new claim for the weekly use of Advocate should give veterinary surgeons a more effective route to go down when dealing with more severe cases, compared to monthly use. However, demodicosis is a complex condition which presents the practitioner with many challenges. So, from past experience with this condition, we would urge vets to be patient and also recognise the importance of treating any underlying disease process likely to exacerbate the situation."
Advocate Spot-on Solution has also been recently licensed for the prevention of Angiostrongylus vasorum, and the treatment of Crenosoma vulpis.
For further information, please contact your Bayer representative or the Bayer technical advice line on 0845 1305995.